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DNA synthesis in peripheral blood leucocytes following renal
transplantation. DNA synthesis in peripheral blood leucocytes
following renal transplantation was measured during the post-
operative period in 22 renal allografted patients. Significant
increases in synthesis were considered in relation to rejection
episodes and immunosuppressive therapy. Results in 17 patients
with good renal function showed a correlation between acute
rejection episodes and the presence of a preceding or coincident
period of increased DNA synthesis. Absence of rejection was
associated with an absence of any increase in synthesis. Corti-
costeroid-induced granulocytosis characterized by immature
DNA-synthesizing myeloid cells did not appear to be reflected
in the levels of DNA synthesis unless prednisone in excess of
100 mg/day was administered. In oliguric patients treated with
high doses of prednisone (>200 mg/day), high levels of DNA
synthesis occurred following drug administration. It is con-
cluded that in order for measurement of DNA synthesis to be of
use in the detection of rejection, particularly in oliguric patients,
it is necessary to assess DNA synthesis in lymphocyte suspen-
sions free of any myeloid cells.
Synthèse de DNA dans les leucocytes du sang périphérique
après transplantation rénale. La synthese de DNA dans les
leucocytes du sang périphérique a été mesurée au cours de Ia
période post-opératoire chez 22 malades ayant recu une allo-
greffe. Des augmentations significatives de la synthése ont été
considérées dans leurs rapports avec les episodes de rejet et le
traitment immunodépresseur. Les résultats obtenus chez 17
malades ayant une bonne fonction rénale ont montré une
correlation entre les episodes de rejet aigu et l'existence d'une
période d'augmentation de synthése de DNA préalable ou
coincidante. L'absence de rejet a été associée a l'ahsence d'aug-
mentation de Ia synthese. La granulocytose induite par les
corticostéroIdes, caractérisée par des cellules myeloides im-
matures synthétisant le DNA, n'a pas paru étre reflétée par les
valeurs de Ia synthese de DNA sauf quand Ia prednisone était
administrée a des doses supérieures a 100 mg/jour. Chez les
malades oliguriques traités par des doses de prednisone super-
ieures a 200 mg/jour des valeurs élevées de synthése de DNA ont
été observées au décours de l'administration. II est conclu que
pour qu'elle soit utile a Ia detection du rejet, surtout chez les
malades oliguriques, il est nécessarie de mesurer Ia synthèse du
DNA dans des suspensions de lymphocytes exemptes de toute
cellule myéloide.
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During the past few years increasing interest has
been shown in developing laboratory methods of
detecting rejection crises in patients with renal alto-
grafts before clinical signs are apparent. Many of the
investigations reported depend on the detection and
measurement of changes in the recipients' immune
responses [1—4]. Such methods if successfully deve-
loped would be a valuable aid in postoperative man-
agement leading to a more precise use of immuno-
suppressive drug therapy, especially in those patients
who are oliguric for some time following trans-
plantation.
The present investigation into one of these ap-
proaches was begun shortly after the claim [1] that
increased DNA synthesis in peripheral blood leuco-
cytes preceded clinical rejection by 24 to 48 hr and that
this increase was due to DNA synthesis by immuno-
logically activated lymphocytes in the peripheral
blood. Since then other studies [5, 6] have suggested
that DNA-synthesizing lymphocytes contribute little
to the level of peripheral leucocyte DNA synthesis,
which is apparently greatly affected by the immuno-
suppressive regime following allografting [5].
Therefore, in this study particular attention has
been given to the possibility of detecting relatively
small increases in DNA synthesis, which could be due
to cells of the lymphocytic series, in patients receiving
different daily doses of immunosuppressive drugs.
Methods
Patients. An unselected consecutive series of 22
patients was studied following renal transplantation
during their postoperative period inhospital which
varied from 15 to 53 days. Fourteen patients received
cadaver kidney transplants and eight received kidneys
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from living related donors. On a series of specimens
from these patients, DNA synthesis in peripheral
blood leucocytes was measured and the results com-
pared with rejection status as assessed by existing
standard methods.
In particular, the relationships between levels of
leucocyte DNA synthesis and the first acute rejection
episodes were examined in order to minimize the
possible effects of immunosuppression and infection.
The clinicians in charge of postoperative care employed
standard methods of detecting rejection, namely
constitutional disturbance, local physical signs in
relation to the graft and renal function tests. In patients
with some degree of renal function, most reliance was
placed on concentrations of serum creatinine. In
oliguric patients, where it is difficult clinically to
detect rejection reliably, signs such as fever, hyper-
tension, tachycardia and local pain and swelling of the
graft often gave a clue. Biopsies were carried out in
selected cases. Rejection was diagnosed and treated
without any knowledge of the results of the leucocyte
tests. Similarly, the leucocyte synthetic activity was
assessed in a blind fashion by one of us (A.L.J.) who
was deliberately kept in ignorance of the clinical state
of the patients.
Immunosuppression. Recipients of living donor kid-
neys received prednisone therapy, 40 mg/day, from
the time of operation, while cadaver kidney recipients
received a regimen of 100 mg/day. Azathioprine
therapy was given to both groups in a dose of I to 4
mg/kg of body wt/day according to the level of renal
function and the white blood cell count. When rejec-
tion was diagnosed or strongly suspected, prednisone
dosage was increased to 200 to 400 mg/day and, in
addition, actinomycin C was sometimes employed
together with local irradiation of the kidney (150 r on
three consecutive days).
DNA synthesis in peripheral leucocytes. Wherever
possible daily heparinized peripheral blood samples
were obtained, weekends generally excepted, from
which leucocyte suspensions were prepared. In two of
the living donor recipients, measurements of DNA
synthesis were performed on some days prior to
operation. Dextran (200,000 rnol wt, 6% in saline) was
added at a rate of 2 to 3 mI/lO ml of blood, and
sedimentation at room temperature produced a
leucocyte-rich, red blood cell-contaminated suspension
which was spun, washed twice with Hanks B.S.S.
(Wellcome Laboratories) and resuspended in Medium
199 containing 20°/ fetal bovine serum. Differential
cell counts were made on the final cell suspension; in
most cases granulocytes made up between 20 and 30%
of the total cell population.
Quadruplicate or triplicate cultures in glass tubes
(6 inch x inch) containing either 1 x 106 or 0.5 x 106
lymphocytes were incubated with 1 jCi of tritiated
thymidine (3H Tdr, 5 mCi/mole, Radiochemicals,
Amersham) for two hours in a water bath at 37°C after
an initial 30 mm without isotope. At the end of the
culture period, tubes were cooled in an ice bath and
three volumes of cold isotonic saline solution added.
After the suspension was spun and washed twice with
cold isotonic saline, cold 5% TCA was added. The
precipitate obtained was washed with 5% TCA and
methanol and dissolved overnight in 10 ml of Instagel
(Packard) at 37°C in the dark.
Tritium uptake was counted in a liquid scintillation
counter (Packard series 3000) and the counts corrected
for quenching factor using the channels ratio method.
Results are expressed as the mean cpm per 1 x 106
lymphocytes of four or three cultures. Variability
within quadruplicate or triplicate cultures was fairly
high as has been the experience of workers measuring
DNA synthesis in lymphocytes in various in vitro
techniques [7, 8]. The SEM of all the sets of cultures
was 17.4% so that when the means of successive counts
show an increase greater than a doubling, i.e., in
excess of l00%, the probability that this is a chance
occurrence is less than 5%. Therefore, a significant
increase in DNA synthesis was considered to have
occurred when the mean cpm at least doubled between
consecutive days or over a three-day period and an
increased level was maintained for at least two days.
Results
Kidney function. The patients fell naturally into two
groups in respect of kidney function:
I. A group of 18 patients had a good urine output
from the time of operation, thus allowing reliable
detection of rejection on clinical and biochemical
criteria. In this group no rejection was observed in the
first 72 hr in 11 patients while an immediate post-
transplantation rejection occurred within 72 hr of
operation in 7 patients (Table 1, Nos. 1 through 11
and 12 through 18, respectively).
2. The remaining four patients were oliguric for
most of their stay inhospital (Table I, Nos. 19 through
22).
The second, or oliguric, group differed from those
with good urine output in that rejection was hard to
diagnose on clinical and biochemical grounds.
Steroids were exhibited on suspicion of rejection and
total prednisone dosages were higher for this reason.
DNA synthesis. Daily levels of DNA synthesis were
measured during two distinct periods in relation to
rejection episodes: 1) prior to the first acute clinical
rejection crisis other than the immediate 24 to 72 hr
Table 1. Leucocyte DNA synthesis
Patient Age Sex Presenting kidney Transplant Clinical rejection episodes:
No. years disease cadaver (C)
or living
donor (LD)
following transplantation
Immediately after transplantation(beginning within 72 hr of
transplantation)
22 M Obstructive uropathy LD
2 53 M Malignant hypertension C
3 44 M Polycystic C
4 48 M Malignant hypertension C
5 55 F Polycystic C
6 34 M Glomerulonephritis LD
7 31 M Glomerulonephritis C
8 7 F Pyelonephritis C
9 25 M Glomerulonephritis C
10 50 F Hypertension C
11 32 F Chronic renal failure LD —
12 23 F Glomerulonephritis LD 1—2
13 26 M Pyelonephritis LD 1—2
14 23 M Glomerulonephritis LD 1—2
15 42 F Glomerulonephritis LD 2—3
16 47 M Glomerulonephritis C 2—3
17 48 M Glomerulonephritis LD 1-—2
18 22 F Glomerulonephritis C 3—4
19 44 M Pylonephritis C
20 39 F Glomerulonephritis C
21 34 M Glomerulonephritis C
22 31 F Pylonephritis C
mean of daily cpm during period of increased uptakeIndex of 3H-thymidine uptake increases =
cpm of day preceding increase
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in relation to rejection episodes
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days of occurrence DNA synthesis in pen- Index of 3H- Notes
pheral blood leucocytes
3H-thymidine uptake, cpm
(range)!] x 106
thymidine uptake in-
crease during periods
of raised incorporationAcute
rejection
Subsequent
rejection
Days cpm (range)!
1 x 106 lymphocytes
— — 1—30 94—479 No increase in
synthesis
— — 1—15 208—826 No increase in
synthesis
— — 1—21 75—511 No increase in
synthesis
12 31 1—30 155—1 177 1: 2.2 Raised thymidine uptake
preceding rejection
16 — 1—31 99—1040 1: 3.2 Raised thymidine uptake
preceding rejection
7—9 — —5—16 106—1591 1: 2.8 Raised thymidine uptake
preceding rejection
28—29 40? 1--24 150—2833 1: 4.9 Raised thymidine uptake
preceding rejection
7—9 — 1—7 191—1331 1: 2.5 Raised thyrnidine uptake
preceding rejection
6—7 — 1—18 12—620 No increase in —
synthesis
6—7 — 1—16 132—1563 No increase in
synthesis
6—7 — 1—15 130—462 No increase in Insufficient data prior to
synthesis rejection
1—17 98—872 No increase in
synthesis
7—10 — 1—9 67—525 No increase in
synthesis
— 1—14 778—90,065 1: 36 Greatly increased
thymidine uptake associated
with infection
—— — 1—35 196—64,121 1: 5 Raised thymidine uptake
coincident with rejection
1: 24 Greatly increased thymidine
uptake associated with
infection on days 27—30
12—13 — 1—20 97—347 No increase in
synthesis
7—10 — — 1—16 165—1198 1: 2.6 Raised thymidine uptake
preceding and coincident
with rejection
3—11 30—287 No increase in
synthesis
17—19 33. 45 4—53 180—1573 1: 3.8 Raised thymidine uptake
preceding rejection
16—18 27—28 2—37 100—1116 1: 2.2 Raised thymidine uptake
preceding rejection
18—21 — 1—47 65—3406 1: 3.6 Raised thymidine uptake
preceding rejection
19—21 29 1—38 55—693 No increase in —
synthesis
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Fig. 1.Patient I: no evidence of rejection. Immunosuppression is
at minimal levels and leucocyte thymidine uptake is low.
Fig. 2. Patient 6: An acute rejection episode was diagnosed on (lay
7, leucocyte DNA synthesis was significantly elevated on days 3
and 4. Prednisone dosage was not increased until after the
diagnosis of rejection.
rejection, and 2) the period following the first rejec-
tion crisis.
In one out of the two patients in whom DNA syn-
thesis was measured preoperatively, the levels of
3H-thymidine incorporation dropped after the begin-
ning of immunosuppressive therapy to low levels,
which fluctuated slightly from day to day. In all
patients, levels of DNA synthesis which were regarded
as significantly raised by the criteria already described
ranged between 2- and 36-fold.
Relationship of DNA synthesis to first rejection
episode. The relationship between raised 3H-thymidine
incorporation and rejection for each patient is sum-
marized in Table 1. In one individual (patient 11) data
were incomplete for a critical period of two days prior
to onset of rejection.
In the group of patients (Nos. I through 11, Table 1)
who showed no immediate posttransplantation rejection
and were receiving low levels of immunosuppressive
drugs, three individuals suffered no rejection episodes
at all during their period in hospital and no increases
Fig. 3. Patient 10: A rejection episode occurred on days 6 and?. No
increase in leucocyte DNA synthesis was noted before rejection;
however, no data are available for days 6 and 7. The increased
dosage of prednisone administered to control rejection may be
responsible for increased DNA synthesis on day 16.
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in DNA synthesis were observed (e.g., Fig. 1, patient
1). Seven patients experienced acute rejection episodes,
controlled in two to three days by administration of
increased immunosuppressive drugs. Of these, five
showed a peak of DNA synthesis preceding or coin-
ciding with the rejection episodes (e.g., Fig. 2, patient
6). In two patients no DNA peak occurred before
rejection (e.g., Fig. 3, patient 10).
Seven patients (Nos. 12 through 18, Table 1) dif-
fered from the remainder of the first group in having
an immediate posttransplantation rejection which was
treated with high levels of prednisone and azathio-
prine for a short time.
This immediate posttransplantation rejection occur-
ring up to 72 hr after operation is probably due either
to very low levels of preexisting cross-reacting HL-A
antibodies or a mild Schwartzmann reaction, rather
than an immune response involving lymphocyte
activation following transplantation, and is therefore
not regarded as an acute rejection episode. With the
exception of findings in one of these individuals
(patient 15), the results were similar to those of the
first group of 11. Of three individuals (patients 12, 14
and 18) who had uneventful histories as far as acute
rejection crises were concerned, two had no periods of
increased DNA synthesis (patients 12 and 18) while
greatly increased levels in one (patient 14) appeared to
N
vs
0
x
E
Days after graft
Fig. 4. Patient 19 was oliguric for almost the whole period of
studj'. Serum creatinine concentrations were controlled by
hemodialysis on alternate days. Raised DNA synthesis on days
9 and 10 could be related to a rejection episode which was
confirmed by biopsy on days 17 through 19. Very high leucocyte
DNA synthesis occurred on day 38 which followed closely the
administration of high prednisone dosage.
Table 2. Correlations between levels of DNA synthesis and
presence or absence of acute rejection occurring after 96 hr
following transplantations
Acute rejection
episodes
observed, N
Patients in whom
no acute rejec-
tion occurred, N
Increased DNA"
synthesis 6 1
No increased
DNA synthesis 4 7
P=0.056 (Fishers exact test) This table is based on the results
from the first 18 patients in Table 1 for whom accurate data are
available with regard to rejection episodes. Patient 11 has not
been included as insufficient data were obtained on DNA syn-
thesis prior to rejection.
b Index of 3H-thymidine uptake of between 1:2 and 1:6 of
short duration.
be associated with an acute infection. Of three who
experienced acute rejection crises, one showed ele-
vated DNA concentrations before rejection (patient
17) and two did not (patients 13 and 16).
Four oliguric patients (Nos. 19 through 22, Table
1 and Fig. 4) showed eight periods of increased DNA
synthesis between them. Three of the latter were
associated with eight rejection crises, suspected or
confirmed by biopsy. In these cases it is not possible to
be certain when clinical rejection began. When
biopsy specimens were taken, they only showed that
rejection was occurring or had occurred, and it is not
certain whether the increased levels of DNA synthesis
preceded or followed episodes of rejection.
Table 2 shows the correlations between presence or
absence of increased DNA synthesis and presence or
absence of acute rejection crises for the 17 (patients
1 through 10 and 12 through 18) of the 22 patients
from whom the data are sufficient. A correlation with
a P value of 0.056 exists between increased DNA
synthesis preceding the first acute rejection episodes
on the one hand and no increased DNA synthesis and
absence of rejection on the other.
Immunosuppression and DNA synthesis. Those
patients who experienced no clinical rejection episodes
during the postoperative period inhospital provide
measurements of DNA synthesis in relation to dosage
levels of corticosteroids and azathioprine administered
without the possible complications of the effects of
rejection.
Administration of 40 to 100 mg of prednisone/day
did not give rise to any increase in DNA synthesis
(Fig. 1). Those individuals who experienced an im-
mediate posttransplantation rejection (patients 12
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through 18) were treated with high initial doses of
prednisone (200 mg/day). However, only two patients
(15 and 17) showed high levels of DNA synthesis later
and in one patient (17) this could equally have been
due to a rejection episode.
Patient 15 is of particular interest as the increased
immunosuppressive treatment of the immediate re-
jection coincided with an increase in DNA synthesis
which was not followed by a rejection episode, sug-
gesting that such a rejection episode may have been
suppressed.
The group of patients who were oliguric (19 through
22) present a more confused picture. All received
higher doses of prednisone (200 mg), and sometimes
azathioprine, than the other groups. Three (19 through
21) showed early peaks of DNA synthesis which were,
however, short-lived and as rejection could not be
determined clinically at any particular time after
grafting these peaks could have been related to the
dosage of corticosteroids administered.
Azathioprine. There is insufficient information in
the present series as to the possible effects of with-
drawal of azathioprine on subsequent DNA synthesis.
However, two patients showed azathioprine sensitivity
and had extremely low lymphocyte counts. One of
these showed no increase in DNA synthesis although
rejection episodes were known to have occurred
(patient 22).
Occurrence of infection. While immunosuppression
carries the risk of infection, in this series only two
patients had severe acute infections (14 and 15) and no
cases of hepatitis occurred. In both patients the highest
levels of DNA synthesis in the series were recorded
producing a pattern quite unlike and easily distin-
guished from the short-lived DNA episodes occurring
prior to rejection.
Discussion
Two main assumptions underly the use of increases
in the levels of DNA synthesis in peripheral leucocytes
as a means of detecting rejection episodes. These are,
firstly, that after exposure to foreign histocompability
antigens, circulating immunocompetent cells (i.e.,
lymphocytes) show increased DNA synthesis which is
sufficiently large to be detected; and, secondly, that
the possible effects of factors such as immunosup-
pression and infection are adequately understood.
The first reports on the use of peripheral leucocyte
DNA synthesis measurements for detecting allograft
rejection provided no direct evidence that the DNA
synthesis was due to lymphocytes [1, 2, 9]. However,
observations on renal allografted sheep [10], dogs and
man [11] have shown that large numbers of DNA-
synthesizing cells occur in the efferent lymphatics of the
draining lymph node, and it would appear from the
data presented (Fig. 1 in [11]) that these cells can
be detected in small numbers in peripheral blood. In-
creases in DNA synthesis in peripheral leucocytes
prior to rejection episodes have been found in experi-
mental dog heart allografts in the absence of any
immunosuppression or infection [12]. These increases,
as in the present study, were of limited magnitude and
duration and would only be detected if daily measure-
ments were made and other DNA-synthesizing cells
were not present to any extent.
Cells other than lymphocytes may be found actively
synthesizing both DNA and RNA in peripheral blood.
Parker and Mowbray [131 showed that myeloid cells
were synthesizing RNA apparently in relation to
rejection episodes. However, these myeloid cells are
now thought to be the result of corticosteroid treat-
ment [5], or related to the preoperative uremic con-
dition of the transplanted patient or both [6]. Some
data concerning the effects of corticosteroids on
granulocytes are available; administration of 40 mg
daily of prednisone produces a doubling of granulo-
cyte numbers over a ten-day period while administra-
tion of a single dose of 200 mg is followed in five hours
by a large increase (70%) in granulocyte count [14].
Thus, it seems likely that the administration of large
doses of corticosteroids will lead to the presence of
immature DNA-synthesizing myeloid cells on such a
scale that the detection of small amounts of lymphoid
DNA synthesis is unlikely [4]. No information is
available as to possible differences in the properties of
various corticosteroids in use in renal transplantation
with regard to granulocytosis. Atypical mononuclear
cells in the peripheral blood have also been reported
following bacterial, viral and rickettsial infection [15]
and immunization [16]. However, these are generally
thought to be lymphoid cells.
This suggests that the increased frequency of infec-
tion which occurs in immunosuppressed patients might
be expected to give rise to DNA-synthesizing lympho-
cytes. In the present series very high DNA concentra-
tions were recorded in two patients both associated
with severe infections.
In cadaver kidney transplantation, which is to be the
main definitive form of treatment for end-stage renal
failure in the future, one of the greatest difficulties is
the reliable diagnosis of rejection at an early treatable
stage, in the presence of oliguria. Most clinicians agree
that rejection may be virtually undiagnosable under
these circumstances by clinical methods alone. From
the present investigations, it now appears that a
sudden rise in the levels of DNA synthesis in peri-
pheral leucocytes in an otherwise stable situation is
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highly suggestive of early rejection as yet undiagnosed
clinically. It seems clear that acute infection may cause
a rise in DNA synthesis and also that the rise which
may occur with the start of rejection can be obscured
by marked steroid-induced granulocytosis which
accompanies immunosuppressive therapy. This proli-
feration of the myeloid series at present continues to be
an obstacle, and until satisfactory methods of separa-
ting lymphoid cells from myeloid cells are developed
the establishment of any entirely reliable clinical test
based on DNA synthesis in peripheral lymphocytes
cannot be achieved. Preliminary studies have shown
that Ficoll-Isopaque gradient [17] and nylon or cotton
wool column separation [18] techniques do not
significantly reduce contamination of the lymphocyte
suspensions with immature myeloid cells.
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